HomeCompareGLAPF vs JNJ

GLAPF vs JNJ: Dividend Comparison 2026

GLAPF yields 2.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLAPF wins by $114.5K in total portfolio value
10 years
GLAPF
GLAPF
● Live price
2.14%
Share price
$19.80
Annual div
$0.42
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$134.5K
Annual income
$54,894.60
Full GLAPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GLAPF vs JNJ

📍 GLAPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLAPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLAPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLAPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLAPF
Annual income on $10K today (after 15% tax)
$182.24/yr
After 10yr DRIP, annual income (after tax)
$46,660.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GLAPF beats the other by $45,956.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLAPF + JNJ for your $10,000?

GLAPF: 50%JNJ: 50%
100% JNJ50/50100% GLAPF
Portfolio after 10yr
$77.3K
Annual income
$27,861.19/yr
Blended yield
36.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GLAPF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
4.3
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLAPF buys
0
JNJ buys
0
No recent congressional trades found for GLAPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLAPFJNJ
Forward yield2.14%3.36%
Annual dividend / share$0.42$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR51.4%5.8%
Portfolio after 10y$134.5K$20.0K
Annual income after 10y$54,894.60$827.78
Total dividends collected$106.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GLAPF vs JNJ ($10,000, DRIP)

YearGLAPF PortfolioGLAPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,025$324.60$10,676$355.77+$349.00GLAPF
2$12,303$506.35$11,407$389.39+$896.00GLAPF
3$13,963$799.53$12,198$426.53+$1.8KGLAPF
4$16,225$1,284.00$13,056$467.62+$3.2KGLAPF
5$19,472$2,111.04$13,987$513.12+$5.5KGLAPF
6$24,419$3,584.77$14,998$563.56+$9.4KGLAPF
7$32,490$6,361.15$16,098$619.52+$16.4KGLAPF
8$46,740$11,975.45$17,295$681.69+$29.4KGLAPF
9$74,388$24,376.47$18,599$750.82+$55.8KGLAPF
10$134,490$54,894.60$20,022$827.78+$114.5KGLAPF

GLAPF vs JNJ: Complete Analysis 2026

GLAPFStock

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Full GLAPF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GLAPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLAPF vs SCHDGLAPF vs JEPIGLAPF vs OGLAPF vs KOGLAPF vs MAINGLAPF vs ABBVGLAPF vs MRKGLAPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.